bioRxiv Science⌕ Search

Biology subjects

Simpson, P.

Publications and source records attributed to Simpson, P..

6 recordsLinked to original sources

Adaptive Integration of Heterogeneous Foundation Models to Find Histologically Predictable Genes in Breast Cancer

Foundation models for computational pathology have rapidly emerged as powerful tools for extracting rich biological and morphological representations from histopathology images. However, variations in model architecture, pre-training data, and optimization objectives often lead to task-dependent performance, rather than universal generalization. As a result, effective strategies for integrating their complementary strengths are essential to fully realize the potential of foundation models for robust histopathology analysis. Meanwhile, recent breakthroughs such as spatial transcriptomics provide an unprecedented opportunity to integrate genetic and histopathology information from the same patient sample, thereby maximizing both molecular and anatomical pathology insights. Specifically, each models embedding is first mapped to gene-level predictions via a dedicated prediction head, enabling model-specific feature utilization. A lightweight weighting network then adaptively aggregates these predictions to produce a unified and robust output at gene and spatial location levels. Across multiple spatial transcriptomics datasets, our approach consistently outperforms both individual foundation models and classical ensembling methods. Focusing on breast cancer, we observe substantial gains in prediction accuracy for clinically relevant PAM50 subtype markers and drug-target genes. Moreover, the proposed framework improves interpretability by revealing model-specific contributions and specialization at the gene level. Overall, our work presents an effective solution to integrating multiple foundation models for enhancing the genetic analyses of histopathology images.

bioinformatics↗

Faecalibacterium prausnitzii, depleted in the Parkinson's disease microbiome, improves motor deficits in α-synuclein overexpressing mice

Gut microbiome composition is altered in Parkinsons disease (PD), a neurodegenerative disorder characterized by motor dysfunction and frequently accompanied by gastrointestinal (GI) symptoms. Notably, microbial taxa with anti-inflammatory properties are consistently depleted in PD patients compared to controls. To explore whether specific gut bacteria may be disease-protective, we assembled a microbial consortium of 8 human-associated taxa that are reduced in individuals with PD across multiple cohorts and geographies. Treatment of -synuclein overexpressing (Thy1-ASO) mice, an animal model of PD, with this consortium improved motor and GI deficits. A single bacterial species from this consortium, Faecalibacterium prausnitzii, was sufficient to correct gut microbiome deviations in Thy1-ASO mice, induce anti-inflammatory immune responses, and promote protective colonic gene expression profiles. Accordingly, oral treatment with F. prausnitzii robustly ameliorated motor and GI symptoms and reduced -synuclein aggregates in the brain. These findings support the emerging hypothesis of functional contributions by the microbiome to PD and embolden development of potential probiotic therapies.

physiology↗

Locating the Missing Chlorophylls f in Far-red Photosystem I

The discovery of chlorophyll f-containing oxygenic photosynthesis, with its long-wavelength photochemistry, represented a new low-energy paradigm. However, subsequent structural studies on chlorophyll f-containing Photosystem I (PSI) found five chlorophylls f but none among the photochemically active pigments and concluded that chlorophyll f plays no photochemical role. Here we report a cryo-EM structure (2.01 [A]) of far-red PSI from Chroococcidiopsis thermalis PCC 7203, showing all eight chlorophylls f, including the redox active A-1B. Simulations of absorption difference spectra induced by charge separation indicate that the A-1B chlorophyll f absorbs at 755 nm. The chlorophyll f sites, some wavelength assignments, and conserved far-red-specific amino acids, provide functional insights, including redox tuning of chlorophyll f as the primary donor and far-red excitation energy-sharing over the PSI trimer.

biochemistry↗

Acetyl-CoA carboxylase 1-dependent lipogenesis drives breast cancer progression

Dysregulation of cellular energetics, including lipid synthesis mediated through de novo lipogenesis, is a feature of many cancers. Here we report that acetyl-coenzyme A carboxylase (ACC) 1, the rate-limiting enzyme of de novo lipogenesis, is a key regulator of breast cancer progression and cancer cell phenotype. Mammary epithelial-specific deletion of ACC1 impaired tumour progression and decreased cancer cell proliferation in the PyMT model of breast cancer in vivo. ACC1 knockout in human breast cancer cell lines resulted in decreased cell number and altered cell and membrane morphology. Lipidomic profiling demonstrated reduced levels of acyl-carnitines (CARs) and several phospholipid (PL) classes, whilst also shifting the lipid profiles to exhibit more elongated and less saturated lipids in ACC1 knockout breast cancer cells. Palmitate rescue of ACC1 deletion phenotypes demonstrated a critical role for ACC1 driven de novo lipogenesis in breast cancer cell function. Analysis of human breast tumour-microarrays identified strong ACC1 expression at all breast cancer stages, grade and metastasis, compared to normal adjacent tissue. Together our data demonstrate a novel role for ACC1 in breast cancer progression and cancer cell function, mediated through its lipogenic role, that together with its expression profile, identify ACC1 as a potential therapeutic target in breast cancer. Statement of significanceThis study investigates the impact of ACC1 deletion in breast cancer progression, revealing the importance of ACC1-derived lipids in breast cancer cell phenotypes and identifies ACC1 as a potential novel therapeutic target.

cancer biology↗

Deep spatial-omics to aid personalization of precision medicine in metastatic recurrent Head & Neck Cancers

Immune checkpoint inhibitor (ICI) modality has had a limited success (<20%) in treating metastatic recurrent Head & Neck Oropharyngeal Squamous cell carcinomas (OPSCCs). To improve response rates to ICIs, tailored approaches capable to capture the tumor complexity and dynamics of each patients disease are needed. Here, we performed advanced analyses of spatial proteogenomic technologies to demonstrate that: (i) compared to standard histopathology, spatial transcriptomics better-identified tumor cells and could specifically classify them into two different metabolic states with therapeutic implications; (ii) our new method (Spatial Proteomics-informed cell deconvolution method or SPiD) improved profiling of local immune cell types relevant to disease progression, (iii) identified clinically relevant alternative treatments and a rational explanation for checkpoint inhibitor therapy failure through comparative analysis of pre- and post-failure tumor data and, (iv) discovered ligand-receptor interactions as potential lead targets for personalized drug treatments. Our work establishes a clear path for incorporating spatial-omics in clinical settings to facilitate treatment personalization.

cancer biology↗

Structural and functional insights into the mechanism of action of plant boron transporters

Boron has essential roles in plant growth and development. BOR proteins are key in the active uptake and distribution of boron, and regulation of intracellular boron concentrations. However, their mechanism of action remains poorly studied. BOR proteins are members of the SLC4 family of transporters and thus homologues of well studied mammalian transporters including the human Anion Exchanger 1 (hAE1). Here we generated Arabidopsis thaliana BOR1 (AtBOR1) variants based i) on known disease causing mutations of hAE1 (S466R, A500R) and ii) a loss of function mutation (D311A) identified in the yeast BOR protein, ScBOR1p. The AtBOR1 variants express in yeast and localise to the plasma membrane, although both S466R and A500R exhibit lower expression than the WT AtBOR1 and D311A. The D311A, S466R and A500R mutations result in a loss of boron efflux activity in a yeast bor1p knockout strain. A. thaliana plants containing these three individual mutations exhibit substantially decreased growth phenotypes in soil under conditions of low boron. These data confirm an important role for D311 in the function of the protein and show that mutations equivalent to disease causing mutations in hAE1 have major effects in AtBOR1. We also obtained a low resolution cryo-EM structure of a BOR protein from Oryza sativa, OsBOR3 lacking the 30 C-terminal amino acids. This structure confirms the gate and core domain organisation previously observed for related proteins, and is strongly suggestive of an inward facing conformation.

plant biology↗